| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $441.5M | +82.7% |
| Cost of Revenue | $179.5M | +105.0% |
| Gross Profit | $262.1M | +70.1% |
| R&D Expense | $56.0M | +55.2% |
| SG&A Expense | $168.6M | +41.0% |
| Operating Income | $37.5M | +230.5% |
| Pre-tax Income | $35.8M | +234.2% |
| Income Tax | $316K | +118.6% |
| Net Income | $35.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $97.7M | +53.7% |
| Inventory | $46.6M | +5.2% |
| Current Assets | $497.2M | -2.6% |
| Total Assets | $804.1M | +13.9% |
| Current Liabilities | $59.9M | +9.1% |
| Total Liabilities | $575.5M | +1.2% |
| Stockholders' Equity | $228.6M | +66.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $48.8M | +474.6% |
| Capital Expenditures | $129.7M | -14.6% |
| Investing Cash Flow | -$129.3M | +33.3% |
| Financing Cash Flow | $22.9M | -94.3% |
| Free Cash Flow | -$80.9M | +50.9% |
| +241.7% |
| EPS (Basic) | $1.07 | +239.0% |
| EPS (Diluted) | $1.01 | +231.2% |